Log in
NASDAQ:HAPP

Happiness Biotech Group Stock Forecast, Price & News

$2.01
-0.03 (-1.47 %)
(As of 09/21/2020 12:00 AM ET)
Add
Compare
Today's Range
$1.96
Now: $2.01
$2.06
50-Day Range
$1.96
MA: $2.18
$2.49
52-Week Range
$1.90
Now: $2.01
$6.10
Volume250,583 shs
Average Volume360,541 shs
Market Capitalization$50.25 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Happiness Biotech Group Limited engages in the research, development, manufacture, and sale of nutraceutical and dietary supplements products made of Lucidum spore powder and others in the People's Republic of China. It also offers edible fungi. The company was founded in 2004 and is based in Nanping, the People's Republic of China.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.4Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.61 out of 5 stars


Industry, Sector and Symbol

Industry Medicinals & botanicals
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:HAPP
CUSIPN/A
CIKN/A
Phone86-059-9782-8808

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$65.06 million
Cash Flow$0.53 per share
Book Value$3.18 per share

Profitability

Miscellaneous

EmployeesN/A
Market Cap$50.25 million
Next Earnings DateN/A
OptionableNot Optionable
$2.01
-0.03 (-1.47 %)
(As of 09/21/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive HAPP News and Ratings via Email

Sign-up to receive the latest news and ratings for HAPP and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Happiness Biotech Group (NASDAQ:HAPP) Frequently Asked Questions

How has Happiness Biotech Group's stock price been impacted by COVID-19 (Coronavirus)?

Happiness Biotech Group's stock was trading at $3.82 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, HAPP shares have decreased by 47.4% and is now trading at $2.01.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of Happiness Biotech Group?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Happiness Biotech Group in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Happiness Biotech Group
.

How often does Happiness Biotech Group pay dividends? What is the dividend yield for Happiness Biotech Group?

Happiness Biotech Group declared a -- dividend on Friday, July 31st. Investors of record on Monday, August 10th will be given a dividend of $0.015 per share on Monday, August 17th. The ex-dividend date of this dividend is Friday, August 7th.
View Happiness Biotech Group's dividend history
.

Are investors shorting Happiness Biotech Group?

Happiness Biotech Group saw a increase in short interest in August. As of August 31st, there was short interest totaling 46,400 shares, an increase of 24.7% from the August 15th total of 37,200 shares. Based on an average daily volume of 418,900 shares, the days-to-cover ratio is currently 0.1 days. Currently, 0.5% of the shares of the stock are sold short.
View Happiness Biotech Group's Short Interest
.

Who are some of Happiness Biotech Group's key competitors?

What other stocks do shareholders of Happiness Biotech Group own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Happiness Biotech Group investors own include Aytu Bioscience (AYTU), Heat Biologics (HTBX), AIM ImmunoTech (AIM), Tonix Pharmaceuticals (TNXP), Gilead Sciences (GILD), Ibio (IBIO), NF Energy Saving (BIMI), BioNano Genomics (BNGO), Check Cap (CHEK) and Cocrystal Pharma (COCP).

Who are Happiness Biotech Group's key executives?

Happiness Biotech Group's management team includes the following people:
  • Mr. Xuezhu Wang, CEO & Director (Age 35)
  • Mr. Jiong Bian, Chief Financial Officer (Age 51)

When did Happiness Biotech Group IPO?

(HAPP) raised $11 million in an initial public offering on Friday, October 25th 2019. The company issued 2,000,000 shares at a price of $5.50 per share. Univest Securities served as the underwriter for the IPO and WestPark Capital, Newbridge Securities and Zivest Global were co-managers.

What is Happiness Biotech Group's stock symbol?

Happiness Biotech Group trades on the NASDAQ under the ticker symbol "HAPP."

Who are Happiness Biotech Group's major shareholders?

Happiness Biotech Group's stock is owned by many different institutional and retail investors. Top institutional investors include Marshall Wace LLP (0.25%), Virtu Financial LLC (0.07%), Jane Street Group LLC (0.05%), UBS Group AG (0.04%) and Resources Investment Advisors LLC. (0.04%).

Which institutional investors are buying Happiness Biotech Group stock?

HAPP stock was acquired by a variety of institutional investors in the last quarter, including Marshall Wace LLP, Virtu Financial LLC, Jane Street Group LLC, UBS Group AG, and Resources Investment Advisors LLC..

How do I buy shares of Happiness Biotech Group?

Shares of HAPP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Happiness Biotech Group's stock price today?

One share of HAPP stock can currently be purchased for approximately $2.01.

How big of a company is Happiness Biotech Group?

Happiness Biotech Group has a market capitalization of $50.25 million and generates $65.06 million in revenue each year.

What is Happiness Biotech Group's official website?

The official website for Happiness Biotech Group is www.happ.org.cn.

How can I contact Happiness Biotech Group?

Happiness Biotech Group's mailing address is NO. 11 DONGJIAO EAST ROAD SHUANGXI SHUNCHANG, NANPING F4, 353001. The company can be reached via phone at 86-059-9782-8808.

This page was last updated on 9/22/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.